Jon Snodgres, Chief Financial Officer at REPLIGEN CORP (RGEN), sold 2,046 shares at $86.11 ($176K) on 2020-02-26, disclosed to the SEC on 2020-02-27.
Open-market sale of $176k RGEN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.11 | 946 | $81K | 46.2% |
| 2 | $86.11 | 946 | $81K | 46.2% |
| 3 | $86.86 | 154 | $13K | 7.6% |
| Total | $86.17 avg | 2,046 | $176K | 100% |
| Filing → |
| RGEN | SELL | 2022-08-02 | $440K | — | Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-03-08 | $797K | — | Filing → |